Feedback / Questions
eblasakimab (ASLAN004) - ASLAN Pharma
https://www.globenewswire.com/news-release/2022/06/07/2457503/0/en/ASLAN-Pharmaceuticals-Initiates-Scientific-Collaboration-to-Investigate-the-Distinct-Role-of-IL-13-Receptor-Signaling-in-Atopic-Dermatitis.html
Jun 7, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next